<code id='9744664902'></code><style id='9744664902'></style>
    • <acronym id='9744664902'></acronym>
      <center id='9744664902'><center id='9744664902'><tfoot id='9744664902'></tfoot></center><abbr id='9744664902'><dir id='9744664902'><tfoot id='9744664902'></tfoot><noframes id='9744664902'>

    • <optgroup id='9744664902'><strike id='9744664902'><sup id='9744664902'></sup></strike><code id='9744664902'></code></optgroup>
        1. <b id='9744664902'><label id='9744664902'><select id='9744664902'><dt id='9744664902'><span id='9744664902'></span></dt></select></label></b><u id='9744664902'></u>
          <i id='9744664902'><strike id='9744664902'><tt id='9744664902'><pre id='9744664902'></pre></tt></strike></i>

          entertainment

          entertainment

          author:leisure time    Page View:33477
          Scientist walks up a strand of DNA -- First Opinion coverage from STAT
          Adobe

          Eli Lilly said Tuesday that it will pay $200 million to gene-editing firm Beam Therapeutics for Beam’s stake in Verve Therapeutics, another gene-editing company focused on treatments for heart disease.

          The deal, which also includes future milestone payments, is evidence that despite the pressure on biotechnology stocks there is still interest in very early cutting-edge technologies among big pharmaceutical players. It also provides Beam, which announced on Oct. 19 that it would cut 100 jobs, or 20% of its workforce, to save cash, a large infusion of money.

          advertisement

          “This is like a true win-win-win deal, which is rare in this business, but it’s really, really exciting to see,” said John Evans, Beam’s CEO, in an interview with STAT.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more
          Bernie Sanders is gearing up to subpoena pharma CEOs
          Bernie Sanders is gearing up to subpoena pharma CEOs

          Sen.BernieSandersisaskinghiscolleaguestoissueasubpoenaoftwopharmaceuticalcompanyCEOs.KevinDietsch/Ge

          read more
          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more

          Pancreatic cancer early detection could be helped by AI

          SuzanneKreiter/GlobestaffLimorAppelbaumhasseentoomanypatientswhosefirstsignofafatalillnesscametoolat